|
Use of percentage change in clinical trials
|
|
21
|
10136
|
October 26, 2026
|
|
Relaxing Assumptions and Targeted Estimands with MOST
|
|
14
|
525
|
October 13, 2026
|
|
Bayesian Time Machine
|
|
5
|
190
|
October 12, 2026
|
|
Dichotomization
|
|
91
|
5994
|
October 10, 2026
|
|
RWE: use of target trial emulation framework: why aiming to emulate RCT?
|
|
5
|
1430
|
October 9, 2026
|
|
Randomized non-comparative trials: an oxymoron?
|
|
90
|
5576
|
September 22, 2026
|
|
RCT & Synthetic Data Generating Processes
|
|
0
|
108
|
September 13, 2026
|
|
Oseltamivir (Tamiflu) again proves the need for RCT
|
|
15
|
803
|
August 31, 2026
|
|
Clinicians increased awareness of RCT structure
|
|
1
|
252
|
August 8, 2026
|
|
Cause-Agnostic RCT (CAR)
|
|
10
|
735
|
July 5, 2026
|
|
Statin-related side effects: the recent Lancet publication is biased toward false-negatives
|
|
34
|
1240
|
June 21, 2026
|
|
The Petty/Bone RCT
|
|
111
|
9350
|
June 17, 2026
|
|
Generalizability vs. Transportability in Trials
|
|
79
|
2365
|
June 11, 2026
|
|
Collider in RCT Subgroup Analysis
|
|
34
|
1042
|
June 7, 2026
|
|
The growing interest in integrating causal inference and Design Theory
|
|
13
|
696
|
May 16, 2026
|
|
A/B Testing for Information Gain
|
|
1
|
109
|
April 2, 2026
|
|
One-sided significance threshold of less than 0.1 in Phase 2 clinical trial
|
|
7
|
302
|
February 25, 2026
|
|
Oh dear - wrong interpretation on a coffee study
|
|
8
|
584
|
January 14, 2026
|
|
Should causal modeling be a required part of a NIH grant applications?
|
|
1
|
151
|
December 17, 2025
|
|
Critique of paper on generalizability of oncology trials
|
|
27
|
2766
|
December 10, 2025
|
|
The Design Theory /Causal Inference Divide Explained by the Position of U
|
|
2
|
230
|
November 28, 2025
|
|
Omission of *absolute* risk reduction from NEJM Editorial on PSA testing
|
|
14
|
620
|
November 27, 2025
|
|
Decades of underpowered RCT
|
|
24
|
849
|
November 20, 2025
|
|
Individual response
|
|
266
|
50628
|
November 17, 2025
|
|
Feedback on BayeScores: A Bayesian AFT Mixture Cure Model for Quantifying Clinical Benefit
|
|
3
|
259
|
November 11, 2025
|
|
What is a fake measurement tool and how are they used in RCT
|
|
54
|
21174
|
November 4, 2025
|
|
When and why (not) to worry about the PO assumption
|
|
4
|
859
|
October 9, 2025
|
|
Comparing multiple groups to a reference group
|
|
7
|
327
|
October 6, 2025
|
|
Bayesian Clinical Trials: Interview with Frank Harrell
|
|
0
|
270
|
September 18, 2025
|
|
Should cSM be part of CONSORT
|
|
1
|
160
|
September 12, 2025
|